BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23684830)

  • 21. Transcutaneous immunization with Intercell's vaccine delivery system.
    Seid RC; Look JL; Ruiz C; Frolov V; Flyer D; Schafer J; Ellingsworth L
    Vaccine; 2012 Jun; 30(29):4349-54. PubMed ID: 22682290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The success of microneedle-mediated vaccine delivery into skin.
    Marshall S; Sahm LJ; Moore AC
    Hum Vaccin Immunother; 2016 Nov; 12(11):2975-2983. PubMed ID: 27050528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice.
    Schipper P; van der Maaden K; Groeneveld V; Ruigrok M; Romeijn S; Uleman S; Oomens C; Kersten G; Jiskoot W; Bouwstra J
    J Control Release; 2017 Sep; 262():28-36. PubMed ID: 28710002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.
    Nicolas JF; Guy B
    Expert Rev Vaccines; 2008 Oct; 7(8):1201-14. PubMed ID: 18844594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal naked plasmid DNA immunization: mechanisms of action.
    Elnekave M; Furmanov K; Hovav AH
    Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro-fractional epidermal powder delivery for improved skin vaccination.
    Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
    J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the skin for microneedle delivery of influenza vaccine.
    Koutsonanos DG; Compans RW; Skountzou I
    Adv Exp Med Biol; 2013; 785():121-32. PubMed ID: 23456844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
    Prausnitz MR
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass vaccination: solutions in the skin.
    Glenn GM; Kenney RT
    Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced immunity in intradermal vaccination by novel hollow microneedles.
    Ogai N; Nonaka I; Toda Y; Ono T; Minegishi S; Inou A; Hachiya M; Fukamizu H
    Skin Res Technol; 2018 Nov; 24(4):630-635. PubMed ID: 29707828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Study of Two Droplet-Based Dissolving Microneedle Fabrication Methods for Skin Vaccination.
    Lee C; Kim H; Kim S; Lahiji SF; Ha NY; Yang H; Kang G; Nguyen HYT; Kim Y; Choi MS; Cho NH; Jung H
    Adv Healthc Mater; 2018 Jun; 7(11):e1701381. PubMed ID: 29663698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal vaccination for infants and children.
    Saitoh A; Aizawa Y
    Hum Vaccin Immunother; 2016 Sep; 12(9):2447-55. PubMed ID: 27135736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Needle-free vaccine delivery.
    Kersten G; Hirschberg H
    Expert Opin Drug Deliv; 2007 Sep; 4(5):459-74. PubMed ID: 17880271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous vaccination - Protective immunization is just a skin-deep step away.
    Teunissen MB; Zehrung D
    Vaccine; 2015 Sep; 33(37):4659-62. PubMed ID: 26318246
    [No Abstract]   [Full Text] [Related]  

  • 36. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
    Matsuo K; Hirobe S; Okada N; Nakagawa S
    Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Extended delivery of vaccines to the skin improves immune responses].
    Joyce JC; Sella HE; Jost H; Mistilis MJ; Esser ES; Pradhan P; Toy R; Collins ML; Rota PA; Roy K; Skountzou I; Compans RW; Oberste MS; Weldon WC; Norman JJ; Prausnitz MR
    J Control Release; 2019 Jun; 304():135-145. PubMed ID: 31071375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parameter optimization toward optimal microneedle-based dermal vaccination.
    van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
    Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of transcutaneous vaccination system for infectious disease countermeasure].
    Matsuo K
    Yakugaku Zasshi; 2012; 132(12):1443-50. PubMed ID: 23208052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of an Immune Regulation Technology Targeting the Skin and Promotion of the Practical Applications of Transcutaneous Vaccination/Immunotherapy].
    Okada N
    Yakugaku Zasshi; 2019; 139(9):1129-1137. PubMed ID: 31474627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.